Forward single‐cell sequencing into clinical application: Understanding of ageing and rejuvenation from clinical observation to single‐cell solution

Abstract

Currently under development COVID-19 vaccines still have a long way to go and be available in sufficient supply to cover the whole global population at the same time to confer the much-needed and touted 'herd immunity', whereas BCG is readily available, which can be scaled up at a lower cost to provide the needed respite to vulnerable populations, especially in poor countries.

Advancing precision medicine through single‐cell sequencing: Insights and implications

“…These approaches, informed by a detailed understanding of an individual's cellular landscape, aim to improve the precision and efficacy of medical interventions. Through this nuanced understanding, SCS plays a critical role in advancing the field of precision medicine, emphasising interventions that consider the unique cellular context of each patient, thereby refining treatment efficacy and patient outcomes 3 …”

“…Through this nuanced understanding, SCS plays a critical role in advancing the field of precision medicine, emphasising interventions that consider the unique cellular context of each patient, thereby refining treatment efficacy and patient outcomes. 3 In neurology, the heterogeneity of cell types and their roles in disease pathogenesis present a formidable challenge. SCS has emerged as a critical tool for mapping the cellular landscape of the brain, revealing new cell types and pathways involved in neurological diseases.…”